Jan 2023 Articles

Articles
Generalizability of the REDUCE-IT trial to South Asians with cardiovascular disease
Krishnaraj A, Bakbak E, Teoh H, et al.
Journal:
Med (N Y)

First published: January 10, 2023 DOI: 10.1016/j.medj.2022.12.008
View
- Share
Articles
US Trends in Cholesterol Screening, Lipid Levels, and Lipid-Lowering Medication Use in US Adults, 1999 to 2018
Gao Y, Shah LM, Ding J, et al.
Journal:
J Am Heart Assoc

First published: January 10, 2023 DOI: 10.1161/JAHA.122.028205
View
- Share
Articles
Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial
Ray KK, Troquay RPT, Visseren FLJ, et al.
Journal:
Lancet Diabetes Endocrinol

First published: January 5, 2023 DOI: 10.1016/S2213-8587(22)00353-9
View
- Share
Articles
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias
Tokgozoglu L, Orringer C, Catapano A
Journal:
Eur Heart J

First published: January 2, 2023 DOI: 10.1093/eurheartj/ehac750
View
- Share